Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
120.50
-1.47 (-1.21%)
At close: Mar 25, 2025, 4:00 PM
120.51
+0.01 (0.01%)
After-hours: Mar 25, 2025, 4:53 PM EST
Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences and Applied Markets Group | 3.02B | 3.22B | 3.31B | 3.46B | 3.67B | 3.86B | 4.04B | 4.14B | ||||||||||||||
Life Sciences and Applied Markets Group Growth | -17.80% | -16.62% | -18.15% | -16.47% | -9.72% | -3.77% | 11.16% | 25.37% | ||||||||||||||
Agilent Crosslab Group | 1.94B | 1.64B | 1.62B | 1.61B | 1.59B | 1.57B | 1.55B | 1.51B | ||||||||||||||
Agilent Crosslab Group Growth | 21.55% | 4.85% | 4.98% | 6.56% | 8.01% | 7.99% | -5.96% | -18.22% | ||||||||||||||
Diagnostics and Genomics Group | 1.58B | 1.65B | 1.57B | 1.53B | 1.47B | 1.41B | 1.41B | 1.40B | ||||||||||||||
Diagnostics and Genomics Group Growth | 7.33% | 17.18% | 11.39% | 9.53% | 5.89% | 1.44% | 1.96% | 0.87% |
Revenue by End Market
Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical and Biopharmaceutical | 2.26B | 2.24B | 2.24B | 2.29B | 2.36B | 2.43B | 2.52B | 2.58B | ||||||||||||||
Pharmaceutical and Biopharmaceutical Growth | -4.11% | -7.85% | -11.37% | -11.11% | -7.56% | -3.26% | 3.83% | 8.93% | ||||||||||||||
Chemicals and Advanced Materials | 1.48B | 1.50B | 1.49B | 1.51B | 1.53B | 1.54B | 1.59B | 1.60B | ||||||||||||||
Chemicals and Advanced Materials Growth | -3.07% | -3.11% | -5.99% | -5.26% | -1.61% | 1.45% | 9.38% | 14.48% | ||||||||||||||
Diagnostics and Clinical | 976.00M | 964.00M | 945.00M | 944.00M | 955.00M | 966.00M | 975.00M | 968.00M | ||||||||||||||
Diagnostics and Clinical Growth | 2.20% | -0.21% | -3.08% | -2.48% | -0.42% | 0.31% | 1.14% | -0.41% | ||||||||||||||
Environmental and Forensics | 656.00M | 650.00M | 661.00M | 657.00M | 662.00M | 662.00M | 665.00M | 663.00M | ||||||||||||||
Environmental and Forensics Growth | -0.91% | -1.81% | -0.60% | -0.90% | -0.45% | 0.91% | 4.23% | 5.41% | ||||||||||||||
Food | 603.00M | 592.00M | 596.00M | 603.00M | 625.00M | 628.00M | 643.00M | 643.00M | ||||||||||||||
Food Growth | -3.52% | -5.73% | -7.31% | -6.22% | 0.97% | 1.78% | 7.71% | 9.17% | ||||||||||||||
Academia and Government | 554.00M | 567.00M | 567.00M | 585.00M | 605.00M | 601.00M | 601.00M | 594.00M | ||||||||||||||
Academia and Government Growth | -8.43% | -5.66% | -5.66% | -1.52% | 4.13% | 4.34% | 3.80% | 2.77% |
Revenue by Instrumentation
Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non Instrumentation and Other | 4.18B | 4.16B | 4.11B | 4.12B | 4.12B | 4.09B | 4.07B | 4.02B | ||||||||||||||
Non Instrumentation and Other Growth | 1.50% | 1.59% | 1.03% | 2.41% | 4.22% | 3.81% | 4.87% | 4.58% | ||||||||||||||
Instrumentation | 2.35B | 2.35B | 2.39B | 2.47B | 2.61B | 2.74B | 2.92B | 3.02B | ||||||||||||||
Instrumentation Growth | -10.10% | -14.15% | -18.43% | -18.09% | -12.17% | -5.68% | 5.26% | 12.57% |
Revenue by Type
Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Products | 4.66B | 4.67B | 4.69B | 4.79B | 4.94B | 5.05B | 5.23B | 5.32B | ||||||||||||||
Products Growth | -5.55% | -7.50% | -10.43% | -9.95% | -5.91% | -2.62% | 4.26% | 8.49% | ||||||||||||||
Services and Other | 1.87B | 1.84B | 1.81B | 1.80B | 1.80B | 1.78B | 1.76B | 1.72B | ||||||||||||||
Services and Other Growth | 4.00% | 3.14% | 2.78% | 4.64% | 6.83% | 7.28% | 7.38% | 5.97% |
Revenue by Geography
Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Americas | 2.61B | 2.57B | 2.60B | 2.64B | 2.68B | 2.73B | 2.75B | 2.75B | ||||||||||||||
Americas Growth | -2.36% | -5.82% | -5.46% | -4.11% | -2.09% | 1.86% | 4.41% | 7.22% | ||||||||||||||
APAC | 2.15B | 2.17B | 2.15B | 2.21B | 2.30B | 2.35B | 2.51B | 2.58B | ||||||||||||||
APAC Growth | -6.86% | -7.67% | -14.22% | -14.40% | -7.62% | -4.86% | 7.45% | 14.38% | ||||||||||||||
Europe | 1.78B | 1.77B | 1.75B | 1.75B | 1.76B | 1.75B | 1.74B | 1.71B | ||||||||||||||
Europe Growth | 1.08% | 0.91% | 0.58% | 2.04% | 3.05% | 3.24% | 2.66% | 0.23% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.